ZFA-Logo

Germany’s Drug Commission Cautions Against Cardiac Risks of Domperidone

german translation / full article

Domperidone is a peripheral dopamine antagonist and the second most frequent prokinetic drug precsribed in Germany. After reviewing two new case-control studies from the Netherlands and Canada the European Drug Agency EMA, the British authority and now also Germany´s Drug Commission have recommended special caution when administering domperidone in CVD patients. Moreover the lowest possible dosage should be used and parallel intake of drugs with potential QT-prolongation should strictly be avoided. The French drug bulletin Prescrire suggests to completely abstain from the drug.


(State: 15.02.2013)

Latest Issue 2/2021

In Focus

  • How Much Economy is Tolerated by „Good“ Medicine?
  • Adult Attention-Deficit Hyperactivity Disorder (ADHD)
  • Medical Education in France